AGP Executive Report
Last update: 5 hours agoPharma & M&A: Vicapsys Life Sciences named an advisory board after completing its reverse merger with Stateline Distributors of Puerto Rico, backing strategy for federal/tribal market access and a NitroMist relaunch tied to FDA steps. Small Business Growth: CUD unveiled its 2026-2028 “Fomento Local” plan to expand opportunities for Puerto Rico’s small and midsize firms, including cross-border commerce and easing operating obstacles. Health Policy & Drug Pricing: CMS’s GENEROUS Model now includes all 50 states plus Puerto Rico, with participation agreements due by Sept. 30 and projected Medicaid savings—potentially reshaping coverage and net drug costs. PREPA Bond Fight: The First Circuit upheld subordination of a $8.5B PREPA bondholder claim, limiting what bondholders can recover in Puerto Rico’s restructuring. Government Oversight: FEI expanded its OGPe permitting investigation to examine potential criminal exposure involving DDEC deputy secretary Roberto Lefranc Fortuño. Energy & Costs: Puerto Rico’s clinical labs group is pushing for Medicaid funding and reimbursement reforms while also highlighting the island’s need for stronger federal policy influence. Regulatory Watch: October broadcaster deadlines include EEO public file uploads for Puerto Rico stations and EAS reporting tied to the Nationwide EAS Test.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
